|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 294.30 DKK | +3.85% |
|
-9.81% | -36.90% |
| 11:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09:27am | Wolfe Downgrades Zealand Pharma Following Weak Tolerability Data for Obesity Drug | FW |
Published on 05/07/2026 at 01:11 pm EDT - Modified on 05/06/2026
Zealand Pharma A/S reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was DKK 34 million compared to DKK 8 million a year ago. Net loss was DKK 394 million compared to DKK 335 million a year ago.
Basic loss per share from continuing operations was DKK 5.58 compared to DKK 4.74 a year ago.
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
